Table 2 Mean pre-, post-, six to nine month follow-up scores of GP awareness, practice, knowledge, confidence

Awareness topics (range − 2 to 2)^{c, d}

(n = 698–711)

(n = 591)

(n = 1289–1302)

(n = 652–661)

(n = 356)

(n = 1008–1017)

(n = 86–88)

(n = 50–51)

(n = 136–139)

1.1 Early warning signs for dementia

0.7 (0.8)

0.9 (0.8)

0.8 (0.8)

1.5 (0.5)

1.5 (0.6)

1.5 (0.6)

1.3 (0.5)

1.4 (0.5)

1.3 (0.5)

1.2 Different types of dementia

0.8 (0.8)

0.9 (0.9)

0.8 (0.8)

1.5 (0.5)

1.6 (0.6)

1.5 (0.6)

1.2 (0.6)

1.3 (0.6)

1.2 (0.6)

1.3 Difference between Mild Cognitive Impairment (MCI) and dementia

−0.3 (1.1)

0.5 (1.1)

0.1 (1.2)

1.5 (0.6)

1.5 (0.6)

1.5 (0.6)

0.8 (1.0)

1.1 (0.9)

0.9 (0.9)

1.4 Barriers to diagnosis

0.4 (1.0)

0.8 (0.9)

0.6 (1.0)

1.4 (0.6)

1.4 (0.6)

1.4 (0.6)

1.2 (0.6)

1.3 (0.6)

1.2 (0.6)

1.5 Consequences of not recognizing dementia

0.6 (1.0)

1.0 (0.8)

0.8 (0.9)

1.4 (0.6)

1.5 (0.7)

1.4 (0.6)

1.4 (0.6)

1.5 (0.6)

1.4 (0.6)

1.6 Impact of co-morbidities on dementia diagnosis

0.5 (1.0)

1.0 (0.9)

0.7 (1.0)

1.4 (0.6)

1.5 (0.6)

1.4 (0.6)

1.4 (0.6)

1.4 (0.6)

1.4 (0.6)

1.7 Behavioral and psychological symptoms of dementia (BPSD)

0.6 (0.9)

0.9 (0.9)

0.7 (0.9)

1.5 (0.6)

1.5 (0.6)

1.5 (0.6)

1.3 (0.5)

1.4 (0.5)

1.3 (0.5)

1.8 Caregiver management education, support and referral

0.01 (1.1)

0.8 (1.0)

0.4 (1.1)

1.3 (0.7)

1.5 (0.6)

1.4 (0.7)

1.2 (0.7)

1.2 (0.7)

1.2 (0.7)

1.9 Legal issues and dementia

−0.01 (1.1)

0.8 (1.0)

0.3 (1.1)

1.3 (0.6)

1.5 (0.6)

1.4 (0.6)

1.0 (0.7)

1.2 (0.4)

1.1 (0.6)

1.10 Non-pharmacological management methods for BPSD

0.1 (1.1)

0.7 (1.0)

0.4 (1.1)

1.3 (0.7)

1.4 (0.6)

1.4 (0.7)

1.1 (0.7)

1.3 (0.6)

1.2 (0.6)

1.11 Pharmacological management methods for BPSD

0.1 (1.1)

0.7 (1.0)

0.4 (1.1)

1.3 (0.7)

1.4 (0.7)

1.4 (0.7)

1.1 (0.6)

1.3 (0.6)

1.1 (0.6)

1.12 Use of acetylcholinesterase inhibitors (AChEI) for the management of patients with dementia

0.3 (1.0)

0.7 (1.0)

0.5 (1.0)

1.3 (0.6)

1.4 (0.7)

1.4 (0.6)

1.1 (0.5)

1.0 (0.7)

1.1 (0.6)

1.13 The cumulative anticholinergic effect of medications which can negatively affect cognition in all people especially the elderly

−0.01 (1.7)

0.7 (1.0)

0.3 (1.4)

1.4 (0.7)

1.4 (0.7)

1.4 (0.7)

1.3 (0.6)

1.1 (0.7)

1.2 (0.7)

1.14 The fact that people with dementia are particularly sensitive to adverse effects of medications on cognition such as anticholinergics and sedatives

0.4 (1.1)

0.9 (0.9)

0.6 (1.0)

1.5 (0.6)

1.5 (0.6)

1.5 (0.6)

1.5 (0.6)

1.2 (0.7)

1.4 (0.6)

1.15 The importance of diagnosis and management of dementia in my practice

0.9 (0.9)

1.1 (0.9)

1.0 (0.9)

1.5 (0.5)

1.6 (0.6)

1.6 (0.6)

1.7 (0.5)

1.4 (0.6)

1.6 (0.5)

Face-to-face

Online

Total

Face-to-face

Online

Total

Face-to-face

Online

Total

Practice topics (range 0–4)^{e, f}

(n = 693–703)

(n = 591)

(n = 1284–1294)

(n = 650–658)

(n = 356)

(n = 1006–1014)

(n = 86–87)

(n = 47–49)

(n = 134–136)

2.1 Use assessment tools to help diagnose dementia

2.3 (1.2)

2.4 (1.1)

2.4 (1.1)

3.5 (0.6)

3.4 (0.7)

3.5 (0.7)

3.1 (0.7)

3.1 (0.8)

3.1 (0.8)

2.2 Use pharmacological management methods for BPSD

1.5 (1.0)

1.8 (1.0)

1.6 (1.0)

2.5 (1.0)

2.8 (0.9)

2.6 (1.0)

2.0 (0.8)

2.3 (0.9)

2.1 (0.8)

2.3 Use non-pharmacological management methods for BPSD

1.9 (1.1)

2.1 (1.0)

2.0 (1.0)

3.4 (0.7)

3.3 (0.7)

3.4 (0.7)

2.8 (0.8)

2.8 (0.8)

2.8 (0.8)

2.4 Refer patients to Alzheimer‘s Australia^g

1.5 (1.2)

2.0 (1.2)

1.7 (1.2)

3.4 (0.8)

3.4 (0.8)

3.4 (0.8)

2.5 (1.1)

2.7 (1.1)

2.6 (1.1)

2.5 Assess caregiver stress

2.4 (1.0)

2.5 (1.0)

2.4 (1.0)

3.6 (0.6)

3.5 (0.7)

3.5 (0.6)

3.2 (0.8)

3.2 (0.8)

3.2 (0.8)

2.6 Refer caregivers for counselling

1.8 (1.0)

2.1 (1.1)

1.9 (1.1)

3.2 (0.8)

3.3 (0.8)

3.2 (0.8)

2.4 (0.9)

2.4 (1.2)

2.4 (1.0)

2.7 Counsel patients and their families about legal issues

1.8 (1.1)

2.3 (1.1)

2.0 (1.1)

3.5 (0.7)

3.5 (0.7)

3.5 (0.7)

2.8 (0.9)

1.0 (1.0)

2.8 (1.0)

2.8 Consider the safety of my patient with dementia to drive

2.8 (1.1)

1.0 (1.0)

2.9 (1.0)

3.7 (0.5)

3.6 (0.6)

3.7 (0.6)

3.6 (0.6)

3.6 (0.7)

3.6 (0.6)

Face-to-face

Online

Total

Face-to-face

Online

Total

Face-to-face

Online

Total

Self-perceived level of Knowledge and Confidence (range 0–10)^h

(n = 711)

(n = 591)

(n = 1302)

(n = 660)

(n = 356)

(n = 1016)

(n = 88)

(n = 49)

(n = 137)

Knowledge

5.0 (1.6)

5.2 (2.0)

5.1 (1.8)

7.1 (1.2)

7.6 (1.1)

7.3 (1.2)

7.0 (1.1)

7.3 (1.2)

7.1 (1.1)

Confidence

5.1 (1.8)ⁱ

5.2 (1.9)

5.1 (1.9)^j

7.1 (1.3)

7.7 (1.2)

7.3 (1.3)

7.3 (1.3)

7.6 (1.2)

7.4 (1.3)